Advertisement
Person › Details
Megan Levings (University of British Columbia (UBC))
Levings, Megan (Univ of British Columbia 201610 Professor)
Organisation | University of British Columbia (UBC) | |
Product | transplantation | |
Product 2 | CAR-Treg technology (Chimeric Antigen Receptor T Regulatory cell) | |
Record changed: 2019-11-27 |
Advertisement
More documents for Megan Levings
- [1] Sangamo Therapeutics, Inc.. (11/19/19). "Press Release: Sangamo Announces UK Authorization of a Phase 1/2 Clinical Trial Evaluating the CAR-Treg Cell Therapy TX200 for Kidney Transplantation". Brisbane, CA....
- [2] TxCell S.A.. (7/9/18). "Press Release: TxCell Exercises In-license Option to the University of British Columbia's Intellectual Property Rights of the HLA-A2 CAR-Treg Program". Valbonne....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top